Scholars Central

Conference abstractPublished 16 Sep 2020

Metabonomics discovery of a compound from the microbiome of a genetically modified mouse with anti-obesity properties

Authors: Jeremy R. Everetta

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Metabolic profiling or metabonomics is an important systems biology methodology for disease diagnosis and prognosis. It is also an excellent methodology for the phenotyping of genetically modified mice. We recently used this technology in collaboration with the group of Professor Elizabeth Shephard at UCL, to investigate the metabolic phenotype of a genetically modified mouse that had an unusual, lean phenotype. The genetic modification in this mouse caused a change in its microbiome, and the production by the microbiome, of a new metabolite X. We identified this compound by spectroscopic methods and subsequently showed it to have anti obesity properties and to be responsible for the lean clinical phenotype. This talk will provide an overview of this work and the properties of compound X.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Research Journal of Pharmacy and Pharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Research Journal of Pharmacy and Pharmacology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Jeremy R. Everetta”